LXR-623 5363 InChiKey: NCJPFQPEVDHJAZ-UHFFFAOYSA-N

InChiKey: NCJPFQPEVDHJAZ-UHFFFAOYSA-N

Afuresertib hydrochloride

Application of the nuclear factor-kappaB inhibitor Bay11-7085 for the treatment of endometriosis: an in vitro study

0 µM PND-1186 (>5-fold above IC50) had limited effects on cell proliferation

Chemical Name: hexasodium (1R

LXR-623 5363 InChiKey: NCJPFQPEVDHJAZ-UHFFFAOYSA-NLXR623, also known as WAY 252623, is a highly selective and orally bioavailable synthetic modulator of LXR, which demonstrated efficacy for reducing lesion progression in the murine LDLR( ) atherosclerosis model with no associated increase in hepatic lipogenesis either in this model or Syrian hamsters. In nonhuman primates with normal lipid levels, WAY 252623 significantly reduced total (50 55%) and LDL cholesterol (LDLc) (70 77%) in a time and dose